|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.15 CAD | 0.00% |
|
+38.66% | +52.39% |
| 05/06 | Trulieve Cannabis Announces Uplist to NYSE | MT |
| 14/05 | Trulieve announces proposed domestication from British Columbia to Delaware | RE |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 7.68 | 2.46 | 1.89 | 2.06 | 3.33 | |||||
Return on Total Capital | 8.66 | 2.81 | 2.27 | 2.7 | 4.9 | |||||
Return On Equity % | 1.34 | -10.07 | -26.13 | -11.66 | -9.75 | |||||
Return on Common Equity | 1.39 | -9.74 | -25.75 | -11.17 | -9.14 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 64.72 | 55.09 | 52.13 | 60.32 | 60.21 | |||||
SG&A Margin | 31.96 | 34.68 | 34.2 | 43.02 | 37.69 | |||||
EBITDA Margin % | 35.21 | 24.85 | 23.32 | 21.82 | 27.24 | |||||
EBITA Margin % | 30.69 | 17.56 | 15.32 | 14.72 | 19.61 | |||||
EBIT Margin % | 27.64 | 10.79 | 8.2 | 7.8 | 12.56 | |||||
Income From Continuing Operations Margin % | 1.86 | -16.55 | -38.6 | -13.05 | -9.87 | |||||
Net Income Margin % | 1.92 | -19.85 | -46.65 | -13.07 | -9.85 | |||||
Net Avail. For Common Margin % | 1.92 | -16.01 | -38.15 | -12.59 | -9.38 | |||||
Normalized Net Income Margin | 15.11 | 3.46 | 1.77 | 2.43 | 5.68 | |||||
Levered Free Cash Flow Margin | -11.49 | -1.18 | 14.79 | 4.43 | 14.37 | |||||
Unlevered Free Cash Flow Margin | -9.54 | 2.84 | 19.31 | 7.71 | 17.73 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.44 | 0.36 | 0.37 | 0.42 | 0.42 | |||||
Fixed Assets Turnover | 1.39 | 1.28 | 1.3 | 1.37 | 1.36 | |||||
Receivables Turnover (Average Receivables) | 204.84 | 137.42 | 170.96 | 158.29 | 125.76 | |||||
Inventory Turnover (Average Inventory) | 2.13 | 2.19 | 2.21 | 2.12 | 1.98 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 3.1 | 2.83 | 4.16 | 4.37 | 4.43 | |||||
Quick Ratio | 1.53 | 1.07 | 1.81 | 2.29 | 2.16 | |||||
Operating Cash Flow to Current Liabilities | 0.08 | 0.11 | 1.8 | 1.96 | 2.15 | |||||
Days Sales Outstanding (Average Receivables) | 1.78 | 2.66 | 2.13 | 2.31 | 2.9 | |||||
Days Outstanding Inventory (Average Inventory) | 171.16 | 166.43 | 165.3 | 172.79 | 183.92 | |||||
Average Days Payable Outstanding | 9.86 | 8.7 | 16.87 | 18.14 | 17.84 | |||||
Cash Conversion Cycle (Average Days) | 163.09 | 160.39 | 150.57 | 156.97 | 168.98 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 40 | 53.4 | 56.43 | 66.09 | 49.45 | |||||
Total Debt / Total Capital | 28.57 | 34.81 | 36.07 | 39.79 | 33.09 | |||||
LT Debt/Equity | 38.74 | 51.69 | 54.8 | 63.93 | 46.81 | |||||
Long-Term Debt / Total Capital | 27.67 | 33.7 | 35.03 | 38.49 | 31.32 | |||||
Total Liabilities / Total Assets | 37.04 | 43.29 | 48.38 | 56.48 | 57.6 | |||||
EBIT / Interest Expense | 7.45 | 1.68 | 1.14 | 1.49 | 2.34 | |||||
EBITDA / Interest Expense | 10.02 | 4.23 | 3.6 | 4.71 | 5.61 | |||||
(EBITDA - Capex) / Interest Expense | 1.22 | 1.94 | 3.11 | 2.74 | 4.91 | |||||
Total Debt / EBITDA | 2.47 | 3.05 | 2.71 | 2.82 | 1.59 | |||||
Net Debt / EBITDA | 1.78 | 2.41 | 2.02 | 1.8 | 0.87 | |||||
Total Debt / (EBITDA - Capex) | 20.32 | 6.64 | 3.14 | 4.84 | 1.81 | |||||
Net Debt / (EBITDA - Capex) | 14.63 | 5.25 | 2.34 | 3.09 | 0.99 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 79.93 | 32.18 | -7.31 | 5.07 | -0.45 | |||||
Gross Profit, 1 Yr. Growth % | 56.78 | 12.16 | -14.71 | 21.6 | -0.64 | |||||
EBITDA, 1 Yr. Growth % | 30.51 | -7.79 | -19.19 | -1.69 | 24.29 | |||||
EBITA, 1 Yr. Growth % | 26.85 | -25.16 | -25.8 | 0.95 | 32.59 | |||||
EBIT, 1 Yr. Growth % | 15.75 | -48.94 | -38.86 | -0.17 | 60.37 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -72.31 | -1.16T | 138.69 | -64.47 | -24.69 | |||||
Net Income, 1 Yr. Growth % | -71.38 | -1.46T | 114.09 | -70.56 | -24.97 | |||||
Normalized Net Income, 1 Yr. Growth % | 39 | -70.07 | -63.83 | 44.24 | 132.6 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -77.36 | -857.15 | 139.9 | -65.5 | -26.37 | |||||
Accounts Receivable, 1 Yr. Growth % | 2.77T | 9.79 | 3.01 | 23.65 | 26.65 | |||||
Inventory, 1 Yr. Growth % | 115.83 | 41.86 | -22.92 | 8.56 | 4.72 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 155.27 | 1.74 | -8.97 | 8.33 | -6.81 | |||||
Total Assets, 1 Yr. Growth % | 321.21 | -0.36 | -19.74 | 5.17 | -6.07 | |||||
Tangible Book Value, 1 Yr. Growth % | -8.9 | -57.55 | -91.36 | -713.74 | 47.43 | |||||
Common Equity, 1 Yr. Growth % | 379.08 | -10 | -26.76 | -10.83 | -7.93 | |||||
Cash From Operations, 1 Yr. Growth % | -87.06 | 86.72 | 868.01 | 31.14 | 0.38 | |||||
Capital Expenditures, 1 Yr. Growth % | 109.87 | -40.31 | -77.9 | 203.58 | -63.95 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 1.21T | -86.2 | -2.64T | -68.54 | 253.45 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -4.65T | -141.67 | 454.46 | -58.07 | 141 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 92.66 | 54.18 | 10.08 | -1.31 | 2.28 | |||||
Gross Profit, 2 Yr. CAGR % | 77.93 | 32.79 | -1.59 | 1.91 | 9.92 | |||||
EBITDA, 2 Yr. CAGR % | 61.67 | 10.32 | -11.82 | -7.15 | 10.54 | |||||
EBITA, 2 Yr. CAGR % | 58.16 | -2.09 | -23.3 | -8.27 | 15.7 | |||||
EBIT, 2 Yr. CAGR % | 51.27 | -22.73 | -41.03 | -14.29 | 26.53 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -42.68 | 80.46 | 277.89 | -7.91 | -48.27 | |||||
Net Income, 2 Yr. CAGR % | -41.72 | 97.63 | 440.5 | -20.61 | -53 | |||||
Normalized Net Income, 2 Yr. CAGR % | 47.87 | -35.13 | -63.44 | -14.32 | 83.17 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -48.92 | 41.42 | 229.46 | -9.03 | -49.6 | |||||
Accounts Receivable, 2 Yr. CAGR % | - | 453.71 | -11.72 | 12.86 | 25.14 | |||||
Inventory, 2 Yr. CAGR % | 79.33 | 74.05 | 0.75 | -8.52 | 6.63 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 128.75 | 59.93 | -6.87 | -0.7 | 0.48 | |||||
Total Assets, 2 Yr. CAGR % | 197.26 | 104.88 | -10.56 | -8.13 | -0.61 | |||||
Tangible Book Value, 2 Yr. CAGR % | 62.68 | -33.6 | -78.86 | -27.19 | 200.8 | |||||
Common Equity, 2 Yr. CAGR % | 301.85 | 107.64 | -18.81 | -19.18 | -9.39 | |||||
Cash From Operations, 2 Yr. CAGR % | -17.77 | -51.92 | 383.01 | 256.3 | 14.74 | |||||
Capital Expenditures, 2 Yr. CAGR % | 102.2 | 11.93 | -63.68 | -18.09 | 4.8 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 280.26 | 16.95 | 2.49 | 52.6 | 2.53 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 168.17 | 326.83 | 24.42 | 98 | -0.72 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 108.98 | 69.9 | 29.37 | 8.38 | -1.02 | |||||
Gross Profit, 3 Yr. CAGR % | 96.18 | 52.7 | 14.97 | 5.6 | 1.05 | |||||
EBITDA, 3 Yr. CAGR % | 105.28 | 34.57 | 1.32 | -8.56 | 2.33 | |||||
EBITA, 3 Yr. CAGR % | 101.72 | 23.65 | -8.66 | -15.94 | 3.72 | |||||
EBIT, 3 Yr. CAGR % | 94.79 | 5.68 | -25.5 | -29.72 | 5.61 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 17 | 56.92 | 90.55 | 71.83 | -13.88 | |||||
Net Income, 3 Yr. CAGR % | 18.29 | 66.72 | 102.97 | 104.89 | -22.09 | |||||
Normalized Net Income, 3 Yr. CAGR % | 90.05 | -12.85 | -41.89 | -42.24 | 19.53 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 3.86 | 32.08 | 62.62 | 55.29 | -15.22 | |||||
Accounts Receivable, 3 Yr. CAGR % | - | - | 179.19 | -1.23 | 17.28 | |||||
Inventory, 3 Yr. CAGR % | 57.89 | 65.26 | 29.42 | 3.29 | -4.31 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 139.51 | 73.72 | 29.67 | -2.06 | -2.78 | |||||
Total Assets, 3 Yr. CAGR % | 176.09 | 106.5 | 49.93 | -5.59 | -7.44 | |||||
Tangible Book Value, 3 Yr. CAGR % | 40.41 | 8.59 | -64.06 | -35.02 | -7.89 | |||||
Common Equity, 3 Yr. CAGR % | 174.08 | 144.03 | 46.71 | -16.23 | -15.6 | |||||
Cash From Operations, 3 Yr. CAGR % | -18.14 | 6.5 | 27.65 | 212.77 | 133.58 | |||||
Capital Expenditures, 3 Yr. CAGR % | 91.57 | 34.63 | -34.82 | -26.29 | -37.7 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 58.19 | 25.28 | 149.81 | -30.86 | 95.95 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 51.16 | 41.42 | 383.24 | -13.41 | 107.86 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 466.28 | 128.79 | 61.49 | 36.24 | 17.76 | |||||
Gross Profit, 5 Yr. CAGR % | 196.59 | 105.98 | 48.9 | 30.13 | 12.92 | |||||
EBITDA, 5 Yr. CAGR % | 141.72 | 96.65 | 47.13 | 15.41 | 4.91 | |||||
EBITA, 5 Yr. CAGR % | 133.87 | 85.47 | 37.59 | 8.69 | 0.4 | |||||
EBIT, 5 Yr. CAGR % | 129.01 | 68.26 | 21.43 | -3.98 | -7.92 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 36.67 | 124.81 | 109.14 | 23.88 | 13.11 | |||||
Net Income, 5 Yr. CAGR % | 37.57 | 133.13 | 117.22 | 23.91 | 13.06 | |||||
Normalized Net Income, 5 Yr. CAGR % | 119.23 | 49.94 | -0.63 | -14.95 | -8.02 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | 86.97 | 84.33 | 11.32 | 1.78 | |||||
Accounts Receivable, 5 Yr. CAGR % | - | - | - | - | 102.54 | |||||
Inventory, 5 Yr. CAGR % | 178.66 | 90.11 | 31.64 | 28.52 | 19.77 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 192.68 | 119.13 | 63.65 | 37.09 | 17.09 | |||||
Total Assets, 5 Yr. CAGR % | 240.82 | 151.37 | 75.9 | 49.37 | 27.2 | |||||
Tangible Book Value, 5 Yr. CAGR % | 201.13 | 65.85 | -32.41 | -3.71 | -15.93 | |||||
Common Equity, 5 Yr. CAGR % | 713.87 | 180.5 | 68.47 | 56.84 | 20.99 | |||||
Cash From Operations, 5 Yr. CAGR % | 26.96 | 154.8 | 54.53 | 70.12 | 22.32 | |||||
Capital Expenditures, 5 Yr. CAGR % | 145.1 | 101.45 | -1.49 | 10.36 | -21.24 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | - | 15.86 | 43.74 | 47.79 | 73.77 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | 40.27 | 53.11 | 49.01 | 155.28 |
- Stock Market
- Stocks
- TRUL Stock
- Financials Trulieve Cannabis Corp.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















